A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The US Food and Drug Administration (FDA) ...

Schizophrenia, bipolar disorder, major depressive disorder and other severe mental illnesses affect a greater proportion of patients with chronic kidney disease (CKD).